Laws and FDA approvals continue to evolve, and insurance coverage for these medications could become more available in the future
In a large analysis , people with type 2 diabetes who took 1 mg of semaglutide lowered their A1c by an average of 1.77% after 26 weeks compared to 1.09% with the highest dose of metformin
As prescriptions increased, patients and clinicians began reporting a wider range of adverse effects beyond those described in early clinical trials
Cognitive Function: In some cases shown to improve mood, mental clarity, and focus
4.5.2 Early pregnancy exposure: risk characterization under limited data Existing registry, cohort, and systematic-review data have not identified a stable pattern of major structural malformations after brief early-pregnancy exposure to GLP-1RAs, but the exposed human evidence base remains limited and heterogeneous
It ushered in a whole new class of diabetes medications that are arguably safer, and more effective, than previous treatments were